Human Epididymis Protein 4 (he4) - Gynecology

Relevant Publications

Elucidating the role of liver enzymes as markers and regulators in ovarian cancer: a synergistic approach using Mendelian randomization, single-cell analysis, and clinical evidence.

Issue Release: 2024

Cooperative amplification of Prussian blue as a signal indicator and functionalized metal-organic framework-based electrochemical biosensor for an ultrasensitive HE4 assay.

Issue Release: 2024

Increased serum human epididymis protein 4 is associated with disease activity and systemic involvement in pediatric-onset systemic lupus erythematosus.

Issue Release: 2024

The diagnostic performance of the Mindray system in detecting CA125 and HE4 for patients with ovarian cancer.

Issue Release: 2024

Evaluating the effectiveness of pre-operative diagnosis of ovarian cancer using minimally invasive liquid biopsies by combining serum human epididymis protein 4 and cell-free DNA in patients with an ovarian mass.

Issue Release: 2024

HE4 Serum Levels are Associated with Poor Prognosis in Patients with Acute Heart Failure Combined with Chronic Kidney Disease.

Issue Release: 2024

Effect of human epididymis protein 4 on hyperoxia-induced bronchial dysplasia in newborn rats.

Issue Release: 2024

Mediating and moderating effects of plasma proteomic biomarkers on the association between poor oral health problems and brain white matter microstructural integrity: the UK Biobank study.

Issue Release: 2024

Factors influencing blood tumor marker concentrations in the absence of neoplasia.

Issue Release: 2024

Human epididymis protein 4: Analysis of national health and nutrition examination survey data.

Issue Release: 2024

The effectiveness of CA125 and HE4 as clinical prognostic markers in epithelial ovarian cancer patients with BRCA mutation.

Issue Release: 2024

Machine Learning-Enhanced Extraction of Biomarkers for High-Grade Serous Ovarian Cancer from Proteomics Data.

Issue Release: 2024

Potential for trans-pulmonary tumor markers in the early diagnosis of lung cancer: a case report.

Issue Release: 2024

The clinical importance of IFN-γ and human epididymis protein 4 in Egyptian patients with epithelial ovarian cancer combined with HPV infection.

Issue Release: 2024

Comprehensive serum glycopeptide spectra analysis to identify early-stage epithelial ovarian cancer.

Issue Release: 2024

Diagnostic role of urine human epididymis protein 4 in ovarian cancer.

Issue Release: 2024

Use of Sensor Array Analysis to Detect Ovarian Cancer through Breath, Urine, and Blood: A Case-Control Study.

Issue Release: 2024

Prognostic value of HE4 in advanced-stage, high-grade serous ovarian cancer: Analysis of HE4 kinetics during NACT, predicting surgical outcome and recurrence in comparison to CA125.

Issue Release: 2024

Knockdown of HE4 suppresses tumor growth and invasiveness in lung adenocarcinoma through regulation of EGFR signaling.

Issue Release: 2024

Predicting epithelial ovarian cancer prognosis: correlation of posttreatment F-fluorodeoxyglucose positron emission tomography-computed tomography metabolic parameters, serum carbohydrate antigen, and human epididymis protein levels with overall survival.

Issue Release: 2024

What Are the Challenges in Addressing Human Factors?

What is a Normal Menstrual Cycle?

What is the Role of HIPAA in Research and Clinical Trials?

What Should You Look for When Buying Organic Products?

What Is the Process for Getting a Referral?

What is the best contraceptive method for me?

What Factors Influence Dosage in Gynecology?

Can lifestyle changes improve survival rates?

What are the Risks of Ignoring Abnormal Uterine Volume?

Are There Any Bioactive Compounds for Treating Infections?

Human Epididymis Protein 4 (he4) - Gynecology

Relevant Publications

Partnered Content Networks

Relevant Topics